Topoisomerase I inactivation by reticulol and its in vivo cytotoxicity against B16F10 melanoma

Chemotherapy

Volumn 49, Issue 5, 2003, Pages 257-263

  Lim, Dae Seog ^a   Kwak, Yi Sub ^b   Lee, Kyung Ho ^c   Ko, Si Hwan ^d   Yoon, Won Ho ^e   Lee, Won Young ^d   Kim, Chang Han ^a  

^a Konkuk University   (South Korea)

^b Dong Eui University   (South Korea)

^c Biomedical Research Institute   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Seoil University   (South Korea)

Author keywords

Adriamycin; Antitumor efficacy; B16F10 melanoma; Reticulol; Topoisomerase

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; COUMARIN DERIVATIVE; DNA TOPOISOMERASE; DOXORUBICIN; LIPOCORTIN 5; PHOSPHODIESTERASE INHIBITOR; PROPIDIUM IODIDE; RETICULOL; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BACTERIAL STRAIN; CELL DEATH; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DNA REPLICATION; DNA SUPERCOILING; DNA TRANSCRIPTION; DRUG COMBINATION; DRUG EFFICACY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYMOLOGY; EXPERIMENTAL MELANOMA; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MELANOMA; MELANOMA CELL; METABOLISM; METASTASIS; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; SKIN TUMOR; STAINING; STREPTOVERTICILLIUM; SURVIVAL RATE; TUMOR CELL LINE; TUMOR GROWTH;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; COUMARINS; DNA TOPOISOMERASES, TYPE I; DOXORUBICIN; DRUG THERAPY, COMBINATION; FEMALE; INJECTIONS, INTRAVENOUS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; PHOSPHODIESTERASE INHIBITORS; SKIN NEOPLASMS;

EID: 0141728475     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072451     Document Type: Article

References (28)

1. Mitscher LA, Andres WW, McCrae W: Reticulol, a new metabolic isocoumarin, Experientia 1964;20:258-259.
2. Furutani Y, Shimada M, Hamada M, Takeuchi T, Umezawa H: Reticulol, an inhibitor of cyclic adenosine 3′,5′-monophosphate phosphodiesterase. J Antibiot (Tokyo) 1975;28:558-560.
3. Lim D-S, Yoon S-K, Lee M-S, Yoon W-H, Kim C-H: Isolation and identification of Streptoverticillium sp. NA-4803 producing antifungal substance. Korean J Appl Microbiol Biotechnol 1996;24:664-670.
4. Grossman D, Altieri DC: Drug resistance in melanoma: Mechanisms, apoptotis, and new potential therapeutic targets. Cancer Metastasis Rev 2001;20:3-11.
5. Lynch BJ, Komaromy-Hiller G, Bronstein IB, Holden JA: Expression of DNA topoisomerase I, DNA topoisomerase II-alpha, and p53 in metastatic malignant melanoma. Hum Pathol 1998;29:1240-1245.
6. Mu XC, Tran TA, Ross JS, Carlson JA: Topoisomerase II-alpha expression in melanocytic nevi and malignant melanoma. J Cutan Pathol 2000;27:242-248.
7. Lage H, Helmbach H, Dietel M, Schadendorf D: Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance. Br J Cancer 2000;82:488-491.
8. Campain JA, Slovak ML, Schoenlein PV, Popescu NC, Gottesman MM, Pastan I: Acquisition of multiple copies of a mutant topoisomerase II-alpha allele by chromosome 17 aneuploidy is associated with etoposide resistance in human melanoma cell lines. Somat Cell Mol Genet 1995;21:451-471.
9. Silber R, Degar B, Costin D, Newcomb EW, Mani M, Rosenberg CR, Morse L, Drygas JC, Canellakis ZN, Potmesil M: Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Blood 1994;84:3440-3446.
10. Garg LC, DiAngelo S, Jacob ST: Role of DNA topoisomerase I in the transcription of super-coiled rDNA gene. Proc Natl Acad Sci USA 1987;84:3185-3188.
11. Jaxel C, Kohn KW, Wani MC, Wall ME, Pommier Y: Structure activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: Evidence for a specific receptor site and a relation to antitumor activity. Cancer Res 1989;49:1465-1469.
12. Schneider E, Hsiang YH, Liu LF: DNA topoisomerase as anticancer drug targets. Adv Pharmacol 1990;21:149-183.
13. Ren J, Jenkins TC, Chaires JB: Energetics of DNA intercalation reactions. Biochemistry 2000;39:8439-8447.
14. Goormaghtigh E, Chatelain P, Caspers J, Ruysschaert JM: Evidence of a specific complex between Adriamycin and negatively charged phospholipids. Biochim Biophys Acta 1980;597:1-14.
15. Bachur NR, Gordon SL, Geen MV: Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. Mol Pharmacol 1977;13:901-910.
16. Streckyte G, Didziapetriene J, Grazeliene G, Prasmickiene G, Sukeliene D, Kazlauskaite N, Characiejus D, Griciute L, Rotomskis R: Effects of photodynamic therapy in combination with Adriamycin. Cancer Lett 1999;146:73-86.
17. Rigatos SK, Stathopoulos GP, Dontas I, Perrea-Kotsarelis D, Couris E, Karayannacos PE, Deliconstantinos G: Investigation of doxorubicin tissue toxicity: Does amifostine provide chemoprotection? An experimental study. Anticancer Res 2002;22:129-134.
18. Eroglu E, Sari A, Altuntas I, Delibas N, Candir C, Agalar F: The effect of GM-CSF (granulocyte macrophage colony stimulating factor) on doxorubicin induced tissue necrosis and wound healing. Indian J Cancer 2000;37:153-157.
19. Wang JC: DNA topoisomerases. Annu Rev Biochem 1996;65:635-692.
20. Pommier Y: Diversity of DNA topoisomerases I and inhibitors. Biochimie 1998;80:255-270.
21. Covey JM, Jaxel C, Kohn KW, Pommier Y: Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Cancer Res 1989;49:5016-5022.
22. Daza P, Torreblanca J, Garcia-Herdugo G, Moreno FJ: DNA strand-breaks induced by the topoisomerase I inhibitor camptothecin in unstimulated human white blood cells. Cell Biol Int 2002;26:707-713.
23. Degrassi F, De Salvia R, Tanzarella C, Palitti F: Induction of chromosomal aberrations and SCE by camptothecin, an inhibitor of mammalian topoisomerase I. Mutat Res 1989;211:125-130.
24. Eaton MAW, Hutchinson DW: Isocoumarins from Streptomyces mobaraensis. Tetrahedron Lett 1971;18:1337-1340.
25. Lin J, Yoshida S, Takahashi N: Metabolites produced by Streptomyces mobaraensis. Agric Biol Chem 1971;35:363-369.
26. Matroule JY, Carthy CM, Granville DJ, Jolois O, Hunt DWC, Piette J: Mechanism of colon cancer cell apoptosis mediated by pyropheophobide - a methylester photosensitization. Oncogene 2001;20:4070-4084.
27. Gaynor EM, Chen ISY: Analysis of apoptosis induced HIV-1 Vpr and examination of the possible role of the hHR23A protein. Exp Cell Res 2001;267:243-257.
28. Wilkins RC, Kutzner BC, Truong M, Sanchez-Dardon J, McLean JR: Analysis of radiation-induced apoptosis in human lymphocytes: Flow cytometry using Annexin V and propidium iodide versus the neutral comet assay. Cytometry 2002;48:14-19.